<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Research &amp; Innovation Services</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/ACF68965-0329-4449-B6A0-1FE1DDCF9409"><gtr:id>ACF68965-0329-4449-B6A0-1FE1DDCF9409</gtr:id><gtr:firstName>Natalia N</gtr:firstName><gtr:surname>Nalivaeva</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FAB06145-89EB-432F-A39D-75803C4D7340"><gtr:id>FAB06145-89EB-432F-A39D-75803C4D7340</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/27F1E87B-161B-451A-8371-B9B80BF10ED3"><gtr:id>27F1E87B-161B-451A-8371-B9B80BF10ED3</gtr:id><gtr:firstName>Nikolai</gtr:firstName><gtr:surname>Belyaev</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501565"><gtr:id>77CE295C-8E24-4CB7-B8DB-683332BAA79D</gtr:id><gtr:title>Exploring mechanisms regulating expression of the amyloid-degrading enzyme neprilysin</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501565</gtr:grantReference><gtr:abstractText>Alzheimer s disease is the most common form of senile dementia in the ageing population and puts a significant burden on families, carers and National Health Services in the UK and worldwide. Recently it was found that amyloid deposits in the brain which cause AD, can be cleared by some enzymes, namely peptidases, whose activity in the brain declines with age. One of them, an enzyme called neprilysin, was found to be regulated in the brain by amyloid metabolism itself. Understanding the mechanism of this regulation might lead to a new strategy of regulation of this enzyme at the level necessary for healthy functioning of the cells in the brain and prevention of accumulation of toxic amyloid deposits. Moreover, this research will also generate new basic knowledge about mechanisms of regulation of genes involed in pathology of the brain.</gtr:abstractText><gtr:technicalSummary>It is now apparent that amyloid metabolism in the brain is a dynamic process and accumulation of amyloid peptide in the form of neuritic plaques leading to neurodegeneration and Alzheimer?s disease can be prevented by activation of amyloid-degrading enzymes. One of these, an endopeptidase discovered in Leeds and named neprilysin, is a principal contender and its expression in some brain areas reduces with age. The gamma-secretase protein complex, which includes presenilins, may be involved in regulation of neprilysin expression. This project will focus on the molecular mechanisms regulating expression of neprilysin (and other amyloid-degrading enzymes) in developing and ageing brain which will include analysis of chromatin composition of the neprilysin gene in active and downregulated states using the chromatin immunoprecipitation technique and whether presenilin regulation is direct or indirect. This will allow us to formulate strategies for up-regulation of expression of these metallopeptidases in disease.</gtr:technicalSummary><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>350879</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>media publicity</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>A214ED51-FFDD-4961-A601-EEEC6DC636AC</gtr:id><gtr:impact>An article based on our research activity published in the Observer newspaper in Dec 2008 plus associated media reporting on the BBC (radio 4) and local radio and media (Yorkshire Post)

Quite a lot of feedback/correspondence from members of the public</gtr:impact><gtr:outcomeId>E71E615BC7C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1270000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>304A4841-AC94-4C83-870E-DCDD014B6ABA</gtr:id><gtr:outcomeId>2F06174BF420</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>86000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART PhD Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>EAE7786F-D60F-4531-9A60-841084EABE3D</gtr:id><gtr:outcomeId>C8EAD1076BF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1E962AD2-4394-4282-8D3B-78ED22443BCE</gtr:id><gtr:title>Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5dd409cf763310de09deaf372d1118b"><gtr:id>a5dd409cf763310de09deaf372d1118b</gtr:id><gtr:otherNames>Belyaev ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>DdMSQtSRcgn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4801DCB-C3F1-4F87-A1CA-C49D577B489C</gtr:id><gtr:title>Sodium valproate: an old drug with new roles.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d44e15c61465b5e28d55e404cebd2b6"><gtr:id>0d44e15c61465b5e28d55e404cebd2b6</gtr:id><gtr:otherNames>Nalivaeva NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>D2C218B378D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71589FAC-47AC-440B-93C3-777F3F854E70</gtr:id><gtr:title>Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d44e15c61465b5e28d55e404cebd2b6"><gtr:id>0d44e15c61465b5e28d55e404cebd2b6</gtr:id><gtr:otherNames>Nalivaeva NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_14910_20_22122230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6C2D81C-D374-4717-AB76-6E9BF7182552</gtr:id><gtr:title>The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5dd409cf763310de09deaf372d1118b"><gtr:id>a5dd409cf763310de09deaf372d1118b</gtr:id><gtr:otherNames>Belyaev ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>PzHdBzVq8D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8E08493-C1C9-4E2E-B577-0B7BB94F3C76</gtr:id><gtr:title>Changes in the Activity of Amyloid-Degrading Metallopeptidases Leads to Disruption of Memory in Rats</gtr:title><gtr:parentPublicationTitle>Neuroscience and Behavioral Physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c63f2bd0c2875dd6ea4b922c4190ceb"><gtr:id>4c63f2bd0c2875dd6ea4b922c4190ceb</gtr:id><gtr:otherNames>Dubrovskaya N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>RfBCEANLP2M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCF27989-F36A-4DB3-85AE-B19D5286ED2C</gtr:id><gtr:title>The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e800021f1d2d46d8c34c5b180495b4e"><gtr:id>1e800021f1d2d46d8c34c5b180495b4e</gtr:id><gtr:otherNames>Hong Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>pm_14910_20_21365649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21DEB1C2-E16B-410D-B1C2-F54577F1ACB9</gtr:id><gtr:title>Cell biology, regulation and inhibition of beta-secretase (BACE-1).</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38ec85c65f8b856d39dae0c50ec3e9ba"><gtr:id>38ec85c65f8b856d39dae0c50ec3e9ba</gtr:id><gtr:otherNames>Hunt CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>25504FB0D83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14BF6AFD-2A32-40B6-819C-8AA75C6869FA</gtr:id><gtr:title>Nuclear signalling by membrane protein intracellular domains: the AICD enigma.</gtr:title><gtr:parentPublicationTitle>Cellular signalling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7dee22bbeafb76f482a8fee3018e19c9"><gtr:id>7dee22bbeafb76f482a8fee3018e19c9</gtr:id><gtr:otherNames>Beckett C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0898-6568</gtr:issn><gtr:outcomeId>pm_14910_20_22024280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA31B767-4492-4763-B8F6-C6DC82A90E20</gtr:id><gtr:title>The amyloid precursor protein: a biochemical enigma in brain development, function and disease.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d44e15c61465b5e28d55e404cebd2b6"><gtr:id>0d44e15c61465b5e28d55e404cebd2b6</gtr:id><gtr:otherNames>Nalivaeva NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>pm_14910_20_23684647</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501565</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>